Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
How does magnetization transfer influence mcDESPOT results?
Multiple sclerosis and infections.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity.
Computer-based diagnosis of illness in historical persons.
The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.
Trial and error in clinical studies: lessons from ATAMS.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Animal models for human herpesvirus 6 infection.
Gait disorders in multiple sclerosis.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Early CNS neurodegeneration in radiologically isolated syndrome.
Peginterferon beta-1a (Plegridy) for multiple sclerosis.
Exercise in the management of persons with multiple sclerosis.
In vivo histology of the myelin g-ratio with magnetic resonance imaging.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage.
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »